FDA approval for Zurnai Auto-Injector: A new weapon in the fight against opioid overdose

FDA approval for Zurnai Auto-Injector: A new weapon in the fight against opioid overdose

In a major development in the battle against the opioid epidemic, Purdue Pharma’s Zurnai Auto-Injector has been granted approval by the US Food and Drug Administration (FDA) for the emergency treatment of opioid overdose. This approval marks a significant step forward in public health efforts to combat the rising tide of opioid-related deaths across the […]

Emergent’s Narcan nasal spray receives OTC nod for opioid overdose treatment

Emergent’s Narcan nasal spray receives OTC nod for opioid overdose treatment

Emergent BioSolutions’ Narcan nasal spray has secured over-the-counter (OTC) designation from the US Food and Drug Administration (FDA), becoming the first and only prescription strength naloxone nasal spray to receive the status in the country. Narcan Naloxone HCl nasal spray 4 mg is indicated for emergency treatment of opioid overdose, including illegal fentanyl, in the […]